Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug MDX2004 targets advanced tumors in early trial

NCT ID NCT07110584

Recruiting now Disease control Sponsor: ModeX Therapeutics, An OPKO Health Company Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new drug, MDX2004, in 235 adults with advanced solid tumors that have spread or cannot be removed. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. Participants must be 18 or older, in good daily function, and have at least one measurable tumor.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADVANCED TUMORS

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Calvary Mater Newcastle

    RECRUITING

    Waratah, New South Wales, 2298, Australia

    Contact Email: •••••@•••••

  • Hadassah University Hospital-Ein Kerem

    RECRUITING

    Jerusalem, 9574409, Israel

    Contact Email: •••••@•••••

  • Liverpool Hospital

    RECRUITING

    Liverpool, New South Wales, 2170, Australia

    Contact Email: •••••@•••••

  • Princess Alexandra Hospital

    RECRUITING

    Woolloongabba, Queensland, 4102, Australia

    Contact Email: •••••@•••••

  • Rambam Health Care Campus

    RECRUITING

    Haifa, 3109601, Israel

    Contact Email: •••••@•••••

  • Tel Aviv Sourasky Medical Center

    RECRUITING

    Tel Aviv, 6423906, Israel

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.